Literature DB >> 21449665

Polymorphisms present in G-protein-coupled receptor kinases and their effect on β-blocker treatment.

Philip W Raake, Walter J Koch, Patrick Most.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21449665      PMCID: PMC4104676          DOI: 10.2217/pgs.11.13

Source DB:  PubMed          Journal:  Pharmacogenomics        ISSN: 1462-2416            Impact factor:   2.533


× No keyword cloud information.
  14 in total

Review 1.  Seven-transmembrane-spanning receptors and heart function.

Authors:  Howard A Rockman; Walter J Koch; Robert J Lefkowitz
Journal:  Nature       Date:  2002-01-10       Impact factor: 49.962

Review 2.  G-protein-coupled receptors: regulatory role of receptor kinases and arrestin proteins.

Authors:  R J Lefkowitz; J Inglese; W J Koch; J Pitcher; H Attramadal; M G Caron
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1992

Review 3.  Gene therapy in heart failure.

Authors:  Leif Erik Vinge; Philip W Raake; Walter J Koch
Journal:  Circ Res       Date:  2008-06-20       Impact factor: 17.367

Review 4.  Beta-blockade in heart failure. Basic concepts and clinical results.

Authors:  M Packer
Journal:  Am J Hypertens       Date:  1998-01       Impact factor: 2.689

5.  Adrenergic signaling polymorphisms and their impact on cardiovascular disease.

Authors:  Gerald W Dorn
Journal:  Physiol Rev       Date:  2010-07       Impact factor: 37.312

6.  A polymorphism of G-protein coupled receptor kinase5 alters agonist-promoted desensitization of beta2-adrenergic receptors.

Authors:  Wayne C H Wang; Kathryn A Mihlbachler; Eugene R Bleecker; Scott T Weiss; Stephen B Liggett
Journal:  Pharmacogenet Genomics       Date:  2008-08       Impact factor: 2.089

7.  Altered expression of beta-adrenergic receptor kinase and beta 1-adrenergic receptors in the failing human heart.

Authors:  M Ungerer; M Böhm; J S Elce; E Erdmann; M J Lohse
Journal:  Circulation       Date:  1993-02       Impact factor: 29.690

8.  Neurohormonal activation in patients with mild or moderately severe congestive heart failure and effects of ramipril. The Ramipril Trial Study Group.

Authors:  A Sigurdsson; O Amtorp; T Gundersen; B Nilsson; J Remes; K Swedberg
Journal:  Br Heart J       Date:  1994-11

9.  Effect of carvedilol on the morbidity of patients with severe chronic heart failure: results of the carvedilol prospective randomized cumulative survival (COPERNICUS) study.

Authors:  Milton Packer; Michael B Fowler; Ellen B Roecker; Andrew J S Coats; Hugo A Katus; Henry Krum; Paul Mohacsi; Jean L Rouleau; Michal Tendera; Christoph Staiger; Terry L Holcslaw; Ildiko Amann-Zalan; David L DeMets
Journal:  Circulation       Date:  2002-10-22       Impact factor: 29.690

10.  Prevention of heart failure: a scientific statement from the American Heart Association Councils on Epidemiology and Prevention, Clinical Cardiology, Cardiovascular Nursing, and High Blood Pressure Research; Quality of Care and Outcomes Research Interdisciplinary Working Group; and Functional Genomics and Translational Biology Interdisciplinary Working Group.

Authors:  Douglas D Schocken; Emelia J Benjamin; Gregg C Fonarow; Harlan M Krumholz; Daniel Levy; George A Mensah; Jagat Narula; Eileen Stuart Shor; James B Young; Yuling Hong
Journal:  Circulation       Date:  2008-04-07       Impact factor: 29.690

View more
  1 in total

Review 1.  Genetic variation, β-blockers, and perioperative myocardial infarction.

Authors:  Peter Nagele; Stephen B Liggett
Journal:  Anesthesiology       Date:  2011-12       Impact factor: 7.892

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.